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Ab s t r Ac t
Sclerosing stromal tumors (SSTs) are benign neoplasm of sex cord stromal tumor of ovary. The tumors occur predominantly in young female 
usually in the 2nd–3rd decades. Incidence is 2–6% of ovarian stromal tumors. It is usually unilateral. Other sex cord stromal tumors of ovary 
comprised fibromas, thecomas, granulosa cell tumor, Leydig cell tumor, and SST. Due to rarity of SST, most of the time it is not always possible 
to predict the presence of SST by clinical and radiological findings. The case is being presented for its rarity as the patient presented with 
unilocular cyst and minimal ascites.
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In t r o d u c t I o n
Sclerosing stromal tumors (SSTs) are a type of benign neoplasm of 
stromal component of ovary. SSTs account 2–6% of ovarian stromal 
tumors. More than 80% of SSTs occur during the 2nd–3rd decades 
with an average age of 27 years.[1] The SSTs are associated with 
estrogen or androgen secretion or both.[2] Most of the reported 
cases of SST are unilateral. All SSTs are managed by surgical 
enucleation and no recurrence has been reported after surgery.[3]
cA s e re p o r t
A 16-year-old girl presented with menstrual irregularities, lower 
abdominal pain, and mild distension of abdomen for 5 months 
in the outpatient Department of Obstetrics/Gynaecology in 
KCGMCH, Karnal.
On physical per abdominal examination, a soft to firm vague 
mass was noted. The mass was non-tender. On radiological 
examination, a right adnexal solid unilocular cystic pelvic mass 
was revealed of size 13 × 11 cm, with unremarkable right fallopian 
tube, left ovary and left fallopian tube, uterus and cervix, and 
minimal ascites. All other routine hematological investigations, 
biochemical tests, tumor markers, and serum hormonal assay were 
within limits.
A right-sided salpingo-oophorectomy was performed and 
specimen was sent for histopathological examination in the 
Department of Pathology, KCGMCH, Karnal. The ascitic fluid was 
tapped and sent for cytological examination.
Pathological Findings
Grossly – on examination, a right side ovarian mass was submitted, 
measuring 11 × 9 × 3.5 cm, weighing 525 g, with attached 
right fallopian tube measuring 4.5 cm in length. The mass was 
gray-white, lobulated, and encapsulated. External surface was 
smooth and showed prominent vascular markings [Figure 1]. On 
cut section, a unilocular cyst was identified. Cyst was filled with 
mucinous material. The cyst lining was smooth. The wall was 
thickened and measured 1 cm. No papillary projections or hard 
solid areas were seen. Focal areas of necrosis and hemorrhage 
were identified [Figure 2].
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Microscopic Examination
Multiple sections examined showed a tumor showing 
pseudolobulations with cellular nodules separated by less cellular 
area of collagenous tissue and edematous connective tissue 
[Figure 3]. The cellular nodule showed admixture of fibroblasts and 
round vacuolated cells, some of which had signet cell appearance 
[Figure  4]. Nodules also showed some prominent thin walled 
staghorn-shaped dilated vessels [Figure  5]. Some focal areas 
showed myxomatous changes. The fallopian tube showed normal 
histology.
Smears prepared from ascitic fluid showed only mesothelial 
cells. No malignant cells were identified.
A diagnosis of SST of the right ovary was made.
dI s c u s s I o n
SST of ovary is a relatively infrequent neoplasm and represents only 
2–6% of primary ovarian tumors.[4] The most common symptoms 
of SST include menstrual irregularities, lower pelvic pain, and 
abdominal distension, related to ovarian mass size. Virilization and 
anovulation may be present as they are associated with estrogen 
and androgen production.[2] SSTs are mostly hormonally inactive, 
if hormonally active, they are usually androgenic and occur most 
frequently during pregnancy. The etiology of the origin of SST is 
still not well established. According to a study by Damajanov et al., 
SSTs are derived from pluripotent immature stromal cells from 
cortex of ovary on the basis of ultrastructural features.[5] Tiltman 
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and Haffajee postulated that SST and thecoma share common 
morphological features and antigenic determinants such as SMA 
and Vimentin.[6] Other serum biomarkers and biochemical essays 
remain normal but CA-125 was elevated in few cases because of 
repeated probing during per abdomen palpation.[4,7] Sonographic 
features include a multilocular cystic mass of heterogeneous or 
hypoechoic echogenicity with irregular thick septae. Early and 
strong peripheral enhancement is a key characteristic feature in 
distinguishing between SSTs and other types of sex cord stromal 
tumors.[8] On magnetic resonance imaging (MRI), they are known 
to be mainly heterogeneous solid tumors showing intermediate 
signal intensity with hyperintense foci corresponding to stromal 
edema on T2-weighted imaging (WI) and striking enhancement 
on contrast-enhanced T1WI.[9] Histologically, it is characterized 
by pseudolobulation pattern with cellular areas and hypocellular 
areas. Cellular areas comprise spindled fibroblast cells and oval to 
polygonal lipid containing vacuolated cells.[10] Some of the clear 
cell show signet ring morphology with edematous edema, maybe 
mistaken for signet ring cell of Krukenberg tumor of ovary, as they 
occur in the 6th–7th decades of life, with bilateral preponderance. 
Histologically, Krukenberg tumors lack pseudolobulation 
pattern.[4] Cellular areas of SST show many thin walled blood 
vessels mimicking a vascular tumor.[11]
SST has to be differentiated from other sex cord tumors. SSTs 
usually present in younger age female, that is, 2nd–3rd decades of life, 
whereas other ovarian sex cord stromal tumors occur in older age 
Figure 2: Cut section of ovary showing unilocular cyst, thickened 
wall, and focal areas of hemorrhage
Figure 3: Both tumors with cellular and hypocellular areas (H and E 
stain, ×20)
Figure 4: Spindle cells and round cells with clear cytoplasm (H and E 
stain, ×40)
Figure 5: Dilated staghorn-shaped vessels (H and E stain, ×20)
Figure 1: Gross specimen of ovary with thickened wall along with 
fallopian tube
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Table 1: Differentiating features of sex cord stromal tumors of ovary[12]
Parameters Sclerosing stromal tumor Fibroma Thecoma Steroid cell tumor
Age 80% under 30 years 10% under 30 years Average age 63 years 25% under 30 years
Function Almost always absent Absent Typically estrogenic Typically androgenic
Gross variegation Yes No No No
Pseudolobulation Yes Rare Rare No
Prominent ectatic vessels Yes Rare Rare Rare
Two cell types Yes No Only in luteinized form No
Hyaline plaques No Common Common No
Behavior Benign Almost always benign Almost always benign Sometimes malignant
group, that is, 5th–6th decades of life.[1] The other sex cord stromal 
tumors of ovary comprised of fibromas, thecomas, granulosa cell 
tumor, Sertoli-Leydig cell tumor, and SSTs [differentiating features 
are mentioned in the Table 1].
• SSTs show positivity for SMA, vimentin, calretinin, ER +, PR+, 
and alpha-inhibin.[6]
• SSTs are negative for S-100 and epithelial markers.[6]
co n c lu s I o n
Since, SSTs are a rare preprodence in ovarian neoplasm, it is not 
always possible to predict the presence of this tumor preoperatively 
on the basis of clinical and radiological investigations. However, 
MRI/CT scan leads over USG in prediction of SST. SST should be 
considered in young females with an ovarian mass and related 
symptom. Hence, the tumor is benign and treated successfully 
by surgical unilateral salpingo-oophorectomy. In this case, SST 
having a unilocular cyst and minimal ascites is a rare presentation. 
Histopathological diagnosis remains the gold standard for its 
diagnosis over the clinical and radiological investigations. IHC can 
be used for confirmation of the diagnosis.
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